RxDoctor Payments Data

Amandeep Juneja

Vascular Surgery · Danbury, CTNPI 1679951123

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.9%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Medtronic at 47.1% of the total. Reporting peaked in 2021 at $3,332 and has fallen 64.1% since, to $1,196 in 2025.

$10,678in general payments, 2019–2025

Across 114 payments — averaging $93.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Silk Road Medical, Inc.$1K
  • Bard Peripheral Vascular, Inc.$898
  • Cook Medical LLC$711
  • Inari Medical, Inc.$472
  • Edwards Lifesciences$446
  • plus $2K from 13 others

What the payments were for

  • Grants$2,50023%
  • Travel & lodging$2,44623%
  • Food & beverage$5,54152%
  • Education$1912%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,678 in reported general payments places this provider in the 55th percentile of 82 vascular surgery providers in Connecticut.

See all vascular surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$146,942
Medicare patients
642
Services billed
1,275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate11$100
Amoxicillin11$62

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Danbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →